Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4282321 | 0.84 | TSHR (0.49) | TSHRPOLBGAALMNAALDH1A1 | |
| SCHEMBL2536347 | 0.83 | GAA (0.50) | TSHRPOLBGAALMNAALDH1A1 | |
| SCHEMBL13610615 | 0.81 | ALDH1A1 (0.50) | TSHRPOLBGAALMNAALDH1A1 | |
| SCHEMBL13610614 | 0.80 | ALDH1A1 (0.49) | TSHRPOLBGAALMNAALDH1A1 | |
| SCHEMBL2690499 | 0.79 | POLB (0.48) | TSHRPOLBGAALMNAALDH1A1 | |
| SCHEMBL25858329 | 0.79 | TSHR (0.44) | TSHRPOLBGAALMNAALDH1A1 | |
| SCHEMBL308634 | 0.78 | TSHR (0.41) | TSHRPOLBGAALMNAALDH1A1 | |
| SCHEMBL13610604 | 0.78 | HTT (0.50) | TSHRALDH1A1MEN1KMT2AHSD17B10 | |
| SCHEMBL28561943 | 0.78 | TSHR (0.50) | TSHRPOLBGAALMNAALDH1A1 | |
| SCHEMBL27925332 | 0.78 | TSHR (0.50) | TSHRPOLBGAALMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7623751-B2 | Compound, polymerizable composition, optical device, and method for producing refractive index profile optical device | FUJIFILM CORPORATION (JP) | 2009-11-24 | — | — | US | disclosed |
| US-20080226244-A1 | Compound, Polymerizable Composition, Optical Device, and Method for Producing Refractive Index Profile Optical Device | FUJIFILM CORPORATION (JP) | 2008-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080226244-A1 | Compound, Polymerizable Composition, Optical Device, and Method for Producing Refractive Index Profile Optical Device | PIEZO1, PFN1, INF2 | TSHR 2398/4885POLB 1299/4885GAA 4455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.